Skip to content

Emotional Prosody Recognition and Decision Making Inf fMRI and Vulnerability to Suicide

Emotional Prosody Recognition and Decision Making Inf fMRI and Vulnerability to Suicide

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02901769
Acronym
EMODES
Enrollment
26
Registered
2016-09-15
Start date
2013-02-01
Completion date
2019-07-01
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Suicide

Brief summary

Suicide is known to be frequent in depression, and in most of the psychiatric diseases. But as it can occur in patients with no psychiatric illness and doesn't occur in every patients with psychiatric illness, it has to be considered henceforth as a specific vulnerability. This trial will study two fMRI paradigms, emotional prosody recognition and decision making, in order to characterize emotional and cognitive trait factors in a population of patients vulnerable to suicide. Four different groups will be constituted : depressed suicide attempters, depressed patients with past history of suicidal acts, depressed patients with no history of suicidal acts and healthy controls. The main goal will be to correlate fMRI activation during the two paradigms in subjects vulnerable to suicide. The secondary goals will be to characterize emotional and cognitive trait factors in these subjects, to demonstrate that those characteristics are independent from depression and to correlate these trait factors with socio-demographic and clinical features with fMRI activations.

Interventions

OTHERfMRI

two fMRI paradigms, emotional prosody recognition and decision making

Sponsors

Rennes University Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Right-handed, * Depressed suicide attempters for the first group, * Depressed patients with past history of suicidal acts for the second group, * Depressed patients with no history of suicidal acts for the third group, * Healthy controls for the fourth group.

Exclusion criteria

* Another psychiatric trouble than depression, * Another psychotrope treatment than SSRI/SNRI and/or benzodiazepine at inclusion and/or one month before, * For the first and secand groups : more than fous suicidals acts within the past 3 years, * Deficits that do not allow test realisation (visual audition troubles, cognitif deficits, * Prosopagnosia, * Pregnancy, * Severe central nervous system disease or somatic disease, * MRI contra-indication, * Major benefiting from a legal protective measure, * No coverage care.

Design outcomes

Primary

MeasureTime frame
fMRI activation area1 day

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 16, 2026